Cargando…

Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease

BACKGROUND: Sphingomyelin (SM) is the major phospholipid in cell membranes and in lipoproteins. In human plasma, SM is mainly found in atherogenic lipoproteins; thus, high levels of SM may promote atherogenesis. METHODS: We investigated in a median follow up of 6.0 years the association of SM with t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schlitt, Axel, Blankenberg, Stefan, Yan, Daoguang, von Gizycki, Hans, Buerke, Michael, Werdan, Karl, Bickel, Christoph, Lackner, Karl J, Meyer, Juergen, Rupprecht, Hans J, Jiang, Xian-Cheng
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1360085/ https://www.ncbi.nlm.nih.gov/pubmed/16396678 http://dx.doi.org/10.1186/1743-7075-3-5

Ejemplares similares

Risk Factors of Coronary Artery Disease in Secondary Prevention—Results from the AtheroGene—Study
por: Zengin, Elvin, et al.
Publicado: (2015)

Comparison of outcome in 1809 patients treated with drug-eluting stents or bare-metal stents in a real-world setting
por: Vogt, Alexander, et al.
Publicado: (2011)

Contribution of vascular cell-derived cytokines to innate and inflammatory pathways in atherogenesis
por: Loppnow, Harald, et al.
Publicado: (2011)

Association of soluble endothelial protein C receptor plasma levels and PROCR rs867186 with cardiovascular risk factors and cardiovascular events in coronary artery disease patients: The Athero Gene Study
por: Kallel, Choumous, et al.
Publicado: (2012)

Statins potently reduce the cytokine-mediated IL-6 release in SMC/MNC cocultures
por: Loppnow, Harald, et al.
Publicado: (2011)

Troponin I Assay for Identification of a Significant Coronary Stenosis in Patients with Suspected Acute Myocardial Infarction and Wide QRS Complex
por: von Jeinsen, Beatrice, et al.
Publicado: (2016)

Staphylococcus aureus α-Toxin Triggers the Synthesis of B-Cell Lymphoma 3 by Human Platelets
por: Schubert, Sebastian, et al.
Publicado: (2011)

Patients with insulin-dependent diabetes or coronary heart disease following rehabilitation express serum fractalkine levels similar to those in healthy control subjects
por: Maegdefessel, Lars, et al.
Publicado: (2009)

ON THE COMPONENTS OF SPHINGOMYELIN
por: Levene, P. A.
Publicado: (1913)

Sphingomyelin Synthase 1 Is Essential for Male Fertility in Mice
por: Wittmann, Anke, et al.
Publicado: (2016)

Impact of sphingomyelin levels on coronary heart disease and left ventricular systolic function in humans
por: Chen, Xueying, et al.
Publicado: (2011)

Raft-based sphingomyelin interactions revealed by new fluorescent sphingomyelin analogs
por: Kinoshita, Masanao, et al.
Publicado: (2017)

Subcellular Targeting Domains of Sphingomyelin Synthase 1 and 2
por: Yeang, Calvin, et al.
Publicado: (2011)

Sphingomyelins and ent-Sphingomyelins Form Homophilic Nano-Subdomains within Liquid Ordered Domains
por: Yano, Yo, et al.
Publicado: (2020)

Ceramide/Sphingomyelin Rheostat Regulated by Sphingomyelin Synthases and Chronic Diseases in Murine Models
por: Taniguchi, Makoto, et al.
Publicado: (2020)

Schock
por: Müller-Werdan, U., et al.
Publicado: (2006)

Alterations to Sphingomyelin Metabolism Affect Hemostasis and Thrombosis
por: Wang, Jue, et al.
Publicado: (2022)

Sphingomyelin generated by sphingomyelin synthase 1 is involved in attachment and infection with Japanese encephalitis virus
por: Taniguchi, Makoto, et al.
Publicado: (2016)

THE EFFECT OF SPHINGOMYELIN ON THE GROWTH OF TUBERCLE BACILLI
por: Dubos, René J.
Publicado: (1948)

Contribution of rare disease patient organisations to medical education
por: von Gizycki, Rainald
Publicado: (2010)

GDF-15 predicts cardiovascular events in acute chest pain patients
por: Tzikas, Stergios, et al.
Publicado: (2017)

Sphingomyelin and progression of renal and coronary heart disease in individuals with type 1 diabetes
por: Pongrac Barlovic, Drazenka, et al.
Publicado: (2020)

Sphingomyelin is the master of its domain
por: Short, Ben
Publicado: (2014)

Nuclear sphingomyelin in neurodegenerative diseases
por: Albi, Elisabetta, et al.
Publicado: (2021)

Ivabradine in Combination with Beta-Blockers in Patients with Chronic Stable Angina After Percutaneous Coronary Intervention
por: Werdan, Karl, et al.
Publicado: (2015)

Adverse Outcome Prediction of Iron Deficiency in Patients with Acute Coronary Syndrome
por: Zeller, Tanja, et al.
Publicado: (2018)

Prognostic Value of Iron-Homeostasis Regulating Peptide Hepcidin in Coronary Heart Disease—Evidence from the Large AtheroGene Study
por: Zeller, Tanja, et al.
Publicado: (2018)

Emphatic visualization of sphingomyelin-rich domains by inter-lipid FRET imaging using fluorescent sphingomyelins
por: Kinoshita, Masanao, et al.
Publicado: (2017)

Sphingomyelin synthase 2 promotes an aggressive breast cancer phenotype by disrupting the homoeostasis of ceramide and sphingomyelin
por: Zheng, Kehong, et al.
Publicado: (2019)

Head-to-Head Comparison of the Incremental Predictive Value of The Three Established Risk Markers, Hs-troponin I, C-Reactive Protein, and NT-proBNP, in Coronary Artery Disease
por: Nikorowitsch, Julius, et al.
Publicado: (2020)

Intrinsic Iron Release Is Associated with Lower Mortality in Patients with Stable Coronary Artery Disease—First Report on the Prospective Relevance of Intrinsic Iron Release
por: Ruhe, Julia, et al.
Publicado: (2018)

Apoptosis and Sphingomyelin Hydrolysis: The Flip Side
por: Green, Douglas R.
Publicado: (2000)

The Multiple Roles of Sphingomyelin in Parkinson’s Disease
por: Signorelli, Paola, et al.
Publicado: (2021)

Deficiency of sphingomyelin synthase 1 but not sphingomyelin synthase 2 reduces bone formation due to impaired osteoblast differentiation
por: Matsumoto, Goichi, et al.
Publicado: (2019)

Diacylglycerol kinase ζ interacts with sphingomyelin synthase 1 and sphingomyelin synthase‐related protein via different regions
por: Furuta, Masataka, et al.
Publicado: (2023)

Cardiac Troponins for the Diagnosis of Acute Myocardial Infarction in Chronic Kidney Disease
por: Kraus, Daniel, et al.
Publicado: (2018)

Norethindrone Acetate in the Medical Management of Adenomyosis
por: Muneyyirci-Delale, Ozgul, et al.
Publicado: (2012)

Factors affecting longitudinal trajectories of plasma sphingomyelins: the Baltimore Longitudinal Study of Aging
por: Mielke, Michelle M, et al.
Publicado: (2015)

Sphingomyelin synthases 1 and 2 exhibit phosphatidylcholine phospholipase C activity
por: Chiang, Yeun-po, et al.
Publicado: (2021)

Plasma sphingomyelins increase in pre-diabetic Korean men with abdominal obesity
por: Im, Seung-Soon, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d311skrc2jqsamho974351tcvg